Pegaspargase

Pegaspargase
Systematic (IUPAC) name
	Pegylated E. coli L-asparagine amidohydrolase
Clinical data
AHFS/Drugs.com	monograph
MedlinePlus	a695031
Pregnancy cat.	C (US)
Legal status	℞-only (US)
Identifiers
CAS number	130167-69-0
ATC code	L01XX24
DrugBank	DB00059
UNII	7D96IR0PPM
Chemical data
Formula	C1377H2208N382O442S17
Mol. mass	31731.9 g/mol
(what is this?) (verify);

Pegaspargase (pron.: /pəˈɡæspərɡeɪz/), trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase^[1] which has undergone PEGylation.

References [edit]

^ "UNM Cancer Center". Retrieved 2007-08-28. ^{[dead link]}
^ Graham ML (2003). "Pegaspargase: a review of clinical studies". Adv. Drug Deliv. Rev. 55 (10): 1293–302. doi:10.1016/S0169-409X(03)00110-8. PMID 14499708.
^ Patel SS, Benfield P (Jun 1996). "New drug profile: pegaspargase (Polyethylene Glycol L-Asparaginase)". Clinical Immunotherapeutics 5 (6): 492–496.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.